Category

• Pipeline1
• Research1

Organizations

• Bausch + Lomb64
• Eyes On Eyecare42
• Alcon, Inc.41
• American Optometric Association34
• Harrow26
• Glaukos25
• Regeneron21
• Aldeyra Therapeutics20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Clinical Trials2
• Inherited Retinal Disease2
• Retina2
• AMD1
• FDA1
• Cell Therapy1
• Partnership1
• Retinitis Pigmentosa1

• Organizations: BlueRock Therapeutics✕

Clear all

Pipeline

FDA grants IND clearance for BlueRock's primary photoreceptor disease cell therapy

New status paves the way for a phase 1/2a trial to evaluate the safety and efficacy of an induced pluripotent cell-derived candidate.

Research

Foundation Fighting Blindness partners with BlueRock Therapeutics on IRD study

Collaboration will add a new cohort to the nonprofit’s Uni-Rare natural history study.